Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V M Sette

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Revista Gaucha De Enfermagem|January 1, 1997
[Nurses' perception of management]V M Sette, A Silva, M C Da Costa, et al.
The Lancet. Respiratory Medicine|September 22, 2025
Retifanlimab versus placebo in combination with platinum-based chemotherapy in patients with first-line non-squamous or squamous metastatic non-small-cell lung cancer (POD1UM-304): a phase 3, multiregional, placebo-controlled, double-blind, randomised studyShun Lu, Oleksandr Vynnychenko, Yaroslav Kulyaba, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Revista Gaucha De Enfermagem|January 1, 1997
[Nurses' perception of management]V M Sette, A Silva, M C Da Costa, et al.
The Lancet. Respiratory Medicine|September 22, 2025
Retifanlimab versus placebo in combination with platinum-based chemotherapy in patients with first-line non-squamous or squamous metastatic non-small-cell lung cancer (POD1UM-304): a phase 3, multiregional, placebo-controlled, double-blind, randomised studyShun Lu, Oleksandr Vynnychenko, Yaroslav Kulyaba, et al.
Pageof 1